Meda AB

Pipers vag 2A,
Solna, 17073
Sweden,
+46 8 630 19 00
www.meda.se

Meda is an international specialty pharma company that is fully represented in Europe and the US through own sales organizations in more than 50 countries. Meda’s products are sold in about 120 countries, and where it lacks a sales organization, it markets and sells its products via agents and other pharmaceutical companies.

M&A Summary

Buy vs Sell

Year ≤ '13 '14 '15 '16 '17 '18 T
Buy (0.2/yr) # 6 1 - - - - 7
vol $3.2B $3.1B $6.3B
Sell (0.2/yr) # - 1 - - - - 1
  8

Top M&A Advisors

Financial Deals
Sign-up to View
1
Legal Deals
Sign-up to View
1

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Rottapharm S.p.A.
$3.1B (2014-07-31)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View

According to our data here at Mergr, Meda AB has acquired 12 companies, including 2 in the last 5 years. A total of 10 acquisitions came from private equity firms. It has also divested 1 asset.

Meda AB’s largest acquisition to date was in 2014, when it acquired Rottapharm for $3.1B. Meda AB has acquired in 3 different US states, and 4 countries. The Company’s most targeted sectors include life science (86%) and medical products (15%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 409 life science companies that have made at least 1 acquisition, 15 have acquired at least 5 companies, and 2 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 29 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 5 platform acquisitions.

Join Mergr and gain access to Meda AB’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.4K Private Equity Firms
  • 119K M&A Transactions
  • 129K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.